Treatment Strategies to Optimize Outcomes With Brentuximab Vedotin: Management of Common and Rare Toxicities
Published: | Updated:
Common AEs associated with brentuximab vedotin, such as peripheral neuropathy and neutropenia, are often manageable with modifications to dose and schedule.
